(+)-Norfenfluramine hydrochloride,
37936-89-3,
UNII-7LC49OH4I8,
7LC49OH4I8,
MFCD11045299,
Norfenfluramine hydrochloride, (S)-,
D-Norfenfluramine hydrochloride,
DTXSID40746617,
Tox21_501246,
CCG-222550,
LP01246,
NCGC00261931-01,
(+)-Norfenfluramine hydrochloride, >=98% (HPLC), powder,
UNII-3005782T7P component PIDLOFBRTWNFAR-FJXQXJEOSA-N,
S-(+)-|A-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride,
Benzeneethanamine, alpha-methyl-3-(trifluoromethyl)-, hydrochloride, (S)-,
S-(+)-alpha-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride,
(2S)-1-[3-(Trifluoromethyl)phenyl]propan-2-amine--hydrogen chloride (1/1),
Benzeneethanamine, alpha-methyl-3-(trifluoromethyl)-, hydrochloride (1:1), (alphaS)-,
JP 92, NSC 43036, S-(+)-alpha-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride,
JP 92,
NSC 43036,
ACN-054840,
(S)-1-(3-(trifluoromethyl)phenyl)propan-2-amine hydrochloride,
(S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE HYDROCHLORIDE,